Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-24-104931)

Filing Details

Accession Number:: 0001104659-24-104931
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-01 16:15:13
Reporting Period:: 2024-09-27

Accepted Time:: 2024-10-01 16:15:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1644963	Avenue Therapeutics Inc.	ATXI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055666	D Jay Kranzler	C/O Avenue Therapeutics, Inc. 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2024-09-27	3	$2.40	123	No	4	P	Direct
Common Stock, Par Value $0.0001	Acquisiton	2024-09-30	497	$2.50	620	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the "Reverse Stock Split") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.